EVALUATION OF FASTING GLUCOSE, FRUCTOSAMINE, HBA1C, AND VITAMIN D IN IMPAIRED GLUCOSE HOMEOSTASIS AND TYPE 2 DIABETES MELLITUS

Main Article Content

Dr. Savita Rathode
Debij Kumar Mehta
Shipra Mathur

Keywords

Type 2 diabetes mellitus; Prediabetic; Fasting plasma glucose; Fructosamine; HbA1c; Vitamin D

Abstract

Introduction: Impaired glucose homeostasis and type 2 diabetes mellitus (T2DM) represent a growing public health burden. While fasting plasma glucose (FPG) and HbA1c are routinely used for diagnosis and monitoring, alternative markers such as fructosamine provide information on short-term glycaemic control. Vitamin D deficiency has also been implicated in glucose dysregulation and insulin resistance.


Aims: To evaluate fasting plasma glucose, fructosamine, HbA1c, and serum vitamin D levels in controls, pre-diabetic patients, and patients with type 2 diabetes mellitus.


Materials and methods: The present study was a Cross-sectional study. This Study was conducted in August 2022– October 2025 duration. Department of Index Medical college Hospital & Research centre, Indore, M. P. The study population included 100 participants in each group (control, pre-diabetic, and diabetic).


Result: In this study, age and gender distribution were comparable across groups (p = 0.996 and 0.911). Vitamin D₃ deficiency was highly prevalent but did not differ significantly among the groups (controls 77.0%, pre-diabetic 63.0%, diabetics 73.0%; p = 0.394). Fructosamine, fasting plasma glucose, and HbA1c levels increased significantly from controls (229.60 ± 12.98 µmol/L, 86.63 ± 9.71 mg/dL, 4.60 ± 0.33%) to pre-diabetic and diabetic participants (p < 0.0001). Serum vitamin D₃ levels showed a significant negative correlation with HbA1c in pre-diabetic (r = −0.337, p = 0.034) and diabetic patients (r = −0.589, p = 0.001), indicating an association between lower vitamin D₃ status and poorer glycaemic control.


Conclusion: Fructosamine is a useful adjunct marker for assessing intermediate-term glycaemic control, especially in pre-diabetes and T2DM. The high prevalence of vitamin D deficiency highlights the need for routine assessment and possible correction to improve glycaemic outcomes.

Abstract 0 | Pdf Downloads 0

References

1. Alarbash AH, Almutairi SN, Alazmi HR, Almutairi A, Almutairi A, ALARBASH AH, Almutairi Sr SN. The Contributions of Glycated Hemoglobin (HbA1c), Triglycerides, and Hypertension to Diabetic Retinopathy: Insights From a Meta-Analysis. Cureus. 2025 Feb 15;17(2).
2. Xie J, Wang ZH, Zhang ZJ, Li YM, Shen C, Meng Y, Zhao WJ, Chen DQ, Sun LY, Wang YF. Adjusted glycated albumin is a novel indicator of glycemic control in patients with macroalbuminuria in diabetic kidney disease. Scientific Reports. 2025 Apr 21;15(1):13812.
3. Probosari E, Subagio HW, Rachmawati B, Muis SF, Tjandra KC, Adiningsih D, Winarni TI. The Impact of Vitamin D Supplementation on Fasting Plasma Glucose, Insulin Sensitivity, and Inflammation in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Nutrients. 2025 Jul 30;17(15):2489.
4. Enverga M, Isidro MJ, Ang-Golangco N. The association between serum 25-hydroxyvitamin D and glycemic control in patients with diabetes mellitus: a single-center retrospective study. Journal of the ASEAN Federation of Endocrine Societies. 2022 Dec 9;38(1):13..
5. Alqahtani RM, Alsulami EF, Alqahtani RM, Alsulami EF. The association between glycated hemoglobin (HbA1c) level and vitamin D level in diabetes mellitus patients: a cross-sectional study. Cureus. 2023 Oct 17;15(10).
6. Rhee CM, Leung AM, Kovesdy CP, Lynch KE, Brent GA, Kalantar‐Zadeh K. Updates on the management of diabetes in dialysis patients. InSeminars in dialysis 2014 Mar (Vol. 27, No. 2, pp. 135-145).
7. Gerber SM, Stickle DF, Ahmed I, Jabbour SA. Glycated hemoglobin, serum proteins, and other markers as tools for monitoring. International Textbook of Diabetes Mellitus. 2015 Apr 17:853-71.
8. Danese E, Montagnana M, Nouvenne A, Lippi G. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes. Journal of diabetes science and technology. 2015 Jan 14;9(2):169-76.
9. Suh S, Kim JH. Glycemic variability: how do they measure it and why is it important?. Diabetes & metabolism journal. 2015 Aug 1;39(4):273-82.
10. Hahr AJ, Molitch ME. Management of diabetes mellitus in patients with chronic kidney disease. Clinical diabetes and endocrinology. 2015 Dec;1:1-9.
11. Tseng HH. The association between vitamin K2 intake and glucose homeostasis in individuals with and without chronic kidney disease (Doctoral dissertation).2016
12. Rosettenstein K, Viecelli A, Yong K, Do Nguyen H, Chakera A, Chan D, Dogra G, Lim EM, Wong G, Lim WH. Diagnostic accuracies of glycated hemoglobin, fructosamine, and homeostasis model assessment of insulin resistance in predicting impaired fasting glucose, impaired glucose tolerance, or new onset diabetes after transplantation. Transplantation. 2016 Jul 1;100(7):1571-9.
13. Di Pino A, Urbano F, Piro S, Purrello F, Rabuazzo AM. Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk. World journal of diabetes. 2016 Oct 10;7(18):423.
14. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker insights. 2016 Jan;11:BMI-S38440.
15. Sumner AE, Duong MT, Aldana PC, Ricks M, Tulloch-Reid MK, Lozier JN, Chung ST, Sacks DB. A1C combined with glycated albumin improves detection of prediabetes in Africans: the Africans in America study. Diabetes care. 2016 Feb 1;39(2):271-7.